NEW YORK (GenomeWeb News) – Bayer CropScience, the agricultural subsidiary of Bayer, and Precision BioSciences announced today that they will collaborate on creating site-specific genome modifications in plants.

Under the deal, Bayer will have non-exclusive access to Precision Bio's Direct Nuclease Editor technology, which can be used to develop novel traits in plants, the firms said. Precision Bio also will supply Bayer with multiple DNE-engineered enzymes for use across the company's crop platforms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.